SOLVE THERAPEUTICS
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics. The company was founded in 2021 and is headquartered in Belmont, California.
SOLVE THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Belmont, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Contact:
858-357-4137
Total Funding:
63.51 M USD
Similar Organizations
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Silverback Therapeutics
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Dave Johnson CEO and Founder @ Solve Therapeutics
CEO and Founder
2021-07-01
Founder
More informations about "Solve Therapeutics"
Solve Therapeutics, Inc. - LinkedIn
Solve Therapeutics, Inc. | 938 followers on LinkedIn. A Biopharmaceutical Company Developing First-In-Class Antibody Drug Conjugate and Bispecific Therapeutics | A Biopharmaceutical Company ...See details»
Solve Therapeutics, Inc. - The Org
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics. The company was founded in 2021 and is headquartered in Belmont, California.See details»
Solve Therapeutics Announces Mission to Advance Novel …
Dec 14, 2022 /PRNewswire/ -- Solve Therapeutics, Inc. (SolveTx), an oncology-focused biopharmaceutical company, announced today its mission to develop novel antibody-based...See details»
Solve Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Solve Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
SOLVE THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SOLVE THERAPEUTICS, INC. of Belmont, CA. Get the latest business insights from Dun & Bradstreet.See details»
Solve Therapeutics - Funding, Financials, Valuation & Investors
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.See details»
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University …
Jun 22, 2023 About Solve Therapeutics Solve Therapeutics, Inc. (SolveTx) is an oncology-focused biopharmaceutical company dedicated to developing novel antibody-based therapies …See details»
Solve Therapeutics, Inc. (Solve Therapeutics, Inc.) - 药物 …
He currently also serves on the BODs of Acelyrin Inc, Alumis Therapeutics, Solve Therapeutics, Personalis, Inc., AC Immune SA, Harpoon Therapeutics, Inc., InCarda Therapeutics, Inc., XyloCor Therapeutics, and Teon Therapeutics, …See details»
Solve Therapeutics | Pharmaceutical | The Pharmaletter …
Jun 3, 2024 Since its founding in late 2021, Solve has been actively pursuing discovery and development efforts at its laboratory facilities in San Diego, California and Durham, North Carolina. The company has licensed or …See details»
Solve Therapeutics, Inc. - Leadership Team | The Org
The Leadership Team at Solve Therapeutics, Inc. drives the strategic vision and operational execution of the company, guiding its innovative research and development of Antibody Drug …See details»
Solve Therapeutics launches to tackle cancer - Labiotech.eu
Dec 15, 2022 Solve Therapeutics, an oncology-focused biopharma company, has launched with the mission of developing novel antibody-based therapies.See details»
Solve Therapeutics - Products, Competitors, Financials, Employees ...
About Solve Therapeutics SolveTX offers a biotechnology platform focused on researching biopharmaceutical medicines. It develops first-in-class antibody-drug conjugates and bispecific …See details»
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University …
SAN DIEGO, CA and DURHAM, NC (June 22, 2023) – Solve Therapeutics, Inc. (SolveTx), a biopharmaceutical company developing novel antibody-based therapeutics, announces the …See details»
Solve Therapeutics Announces Mission to Advance Novel …
Dec 14, 2022 Venture-backed biopharmaceutical company headquartered in San Diego and led by veteran drug developers with strong track records of successPursuing novel antibody …See details»
Solve Therapeutics Company Profile: Overview and Full News …
Solve Therapeutics is a California-based company that operates in the biotechnology industry, specifically focusing on developing innovative therapeutic solutions. The company is dedicated …See details»
Series A - Solve Therapeutics - 2022-01-21 - Crunchbase
Jan 21, 2022 Solve Therapeutics raised $126000000 on 2022-01-21 in Series ASee details»
Solve Therapeutics Announces Mission to Advance Novel
Dec 14, 2022 Solve Therapeutics, Inc. (SolveTx), an oncology-focused biopharmaceutical company, announced today its mission to develop novel antibody-based therapies targeting …See details»
Solve Therapeutics Announces Mission to Advance Novel …
Dec 14, 2022 Venture-backed biopharmaceutical company headquartered in San Diego and led by veteran drug developers with strong track records of success Pursuing novel antibody …See details»
Solve Therapeutics describes new antibody-drug conjugates
Dec 23, 2024 Solve Therapeutics Inc. has identified antibody-drug conjugates comprising an UC-961 antibody or a tyrosine-protein kinase transmembrane receptor ROR2 (ROR2) …See details»